The portfolio maintains a sizable cost advantage over competitors, priced within the second-lowest fee quintile among peers.
Virtus LifeSci Biotech Clinical Trls ETF BBC
Morningstar’s Analysis BBC
Will BBC outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 22.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Viking Therapeutics Inc | 3.16 | 352,805 | Healthcare |
Alpine Immune Sciences Inc | 2.65 | 296,579 | Healthcare |
Cullinan Therapeutics Inc | 2.59 | 289,140 | Healthcare |
Avidity Biosciences Inc Ordinary Shares | 2.54 | 284,074 | Healthcare |
Vera Therapeutics Inc Class A | 2.40 | 268,048 | Healthcare |
Bny Mellon Cash Reserve Usd | 2.07 | 231,644 | Cash and Equivalents |
Sana Biotechnology Inc Ordinary Shares | 1.94 | 217,140 | Healthcare |
Spyre Therapeutics Inc | 1.87 | 208,825 | Healthcare |
Apogee Therapeutics Inc | 1.81 | 202,413 | Healthcare |
Dyne Therapeutics Inc Ordinary Shares | 1.72 | 192,308 | Healthcare |